Platinum Drug Distribution in Cancer Cells and Tumors
- 28 August 2009
- journal article
- review article
- Published by American Chemical Society (ACS) in Chemical Reviews
- Vol. 109 (10), 4911-4920
- https://doi.org/10.1021/cr9001066
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Towards Antitumor Active trans‐Platinum CompoundsEuropean Journal of Inorganic Chemistry, 2009
- A Non-Cross-Linking Platinum−Acridine Agent with Potent Activity in Non-Small-Cell Lung CancerJournal of Medicinal Chemistry, 2008
- cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospectsProceedings of the National Academy of Sciences, 2008
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Transport kinetics of four- and six-coordinate platinum compounds in the multicell layer tumour modelBritish Journal of Cancer, 2007
- Soluble Single-Walled Carbon Nanotubes as Longboat Delivery Systems for Platinum(IV) Anticancer Drug DesignJournal of the American Chemical Society, 2007
- Molecular mechanisms of resistance and toxicity associated with platinating agentsCancer Treatment Reviews, 2006
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003
- Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitationBiochemistry, 1985